Late Breaking Abstract - Phenotyping Mepolizumab EXacerbations in severe eosinophilic asthma (MEX) (2020)
Attributed to:
United Kingdom Refractory Asthma Stratification Programme (RASP-UK)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/13993003.congress-2020.2250
Publication URI: http://dx.doi.org/10.1183/13993003.congress-2020.2250
Type: Conference/Paper/Proceeding/Abstract